Thermo Fisher Scientific is a global leader in providing scientific instruments, reagents, and consumables, with a focus on advancing healthcare, life sciences, and laboratory workflows. The company supports a diverse range of customers, including researchers, clinical laboratories, and pharmaceutical companies, by offering innovative solutions that enable breakthroughs in areas such as diagnostics, drug development, and environmental analysis. With a commitment to quality and efficiency, Thermo Fisher Scientific plays a crucial role in enhancing productivity and scientific discovery across various disciplines while promoting better health outcomes worldwide. Read More
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic move marks a significant pivot for the genomic sequencing giant, as it ventures deeper into the burgeoning fields
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent strategic developments. This significant uptick reflects investor confidence in the life sciences giant's aggressive expansion into high-growth sectors,
Shares of life sciences company Thermo Fisher (NYSE:TMO)
jumped 9% in the afternoon session after the company secured a major manufacturing agreement with biotechnology firm Vaxcyte and announced a new AI-focused partnership.
Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET.
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes:
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Thermo Fisher Scientific shares flashed a power inflow signal at a price of $464.71, after which TMO rose to an intraday high, representing a 3.3% gain.
In a week poised to redefine the landscape of advanced technology, the Technical University of Denmark (DTU) has unveiled two monumental advancements set to send ripples through the financial markets and technology sector. Just days before the current date of September 29, 2025, DTU-led research has demonstrated a groundbreaking quantum
New York, NY – September 26, 2025 – Gold prices are demonstrating remarkable resilience, holding firmly above the $3,750 per ounce mark today, fueled by a confluence of factors including ongoing geopolitical uncertainties and a U.S. core Personal Consumption Expenditures (PCE) price index that remains stubbornly elevated at 2.9%
Over the past six months, Thermo Fisher’s shares (currently trading at $457.50) have posted a disappointing 10.9% loss, well below the S&P 500’s 15.7% gain. This might have investors contemplating their next move.
The third quarter of 2025 has etched itself into financial history, witnessing the U.S. stock market surge to unprecedented heights. The benchmark S&P 500 (SPX) decisively crossed the 6,500 threshold, ultimately closing above 6,600 points, while the Dow Jones Industrial Average (DJI) powered past 46,000.
The global economic landscape is witnessing a notable divergence in inflationary pressures, with much of the world experiencing a moderation in price increases, while the United States grapples with stubbornly high inflation rates. This disparity is not merely a cyclical anomaly but a consequence of distinct domestic policies, particularly tariffs
